| Stage | CXT | % of rev | MGRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $497M | 100.00% | $275M | 100.00% | CXT ×1.81 |
| Gross profit | $198M | 39.81% | $131M | 47.66% | MGRC +7.8pp |
| Operating income | $66M | 13.22% | $74M | 26.93% | MGRC +13.7pp |
| Pre-tax income | $49M | 9.90% | $66M | 24.02% | MGRC +14.1pp |
| Net income | $39M | 7.87% | $49M | 17.77% | MGRC +9.9pp |
| Stage | CXT | MGRC | Gap · A − B |
|---|---|---|---|
| Revenue | $497M100.00% | $275M100.00% | CXT ×1.81 |
| Gross profit | 39.81%$198M | 47.66%$131M | MGRC +7.8pp |
| Operating income | 13.22%$66M | 26.93%$74M | MGRC +13.7pp |
| Pre-tax income | 9.90%$49M | 24.02%$66M | MGRC +14.1pp |
| Net income |
| 7.87%$39M |
| 17.77%$49M |
| MGRC +9.9pp |
No shared counterparties.